Giselle Ojeda, DPM
Podiatrist · Miami Lakes, FLNPI 1710200860
Payments from drug & device makers
What this record shows
This record is dominated by other: $15,000 of the $15,618 with a category attached, or 96.0%. Convatec Inc. accounts for 96.0% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $15,194, more than ten times the $113 reported in 2019. Among podiatrist clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 14 payments — averaging $1115.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$15K
- Johnson & Johnson$242
- Smith+Nephew$154
- Polynovo North America LLC$132
- Access Pro Medical, LLC$29
- Organogenesis Inc.$22
- plus $38 from 2 others
Across 1 payment — averaging $42.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bristol Myers Squibb$43
What the payments were for
- Food & beverage$6184%
- Other$15,00096%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 1 | $15,000 |
| Johnson & Johnson | 2 | $242 |
| Smith+Nephew | 6 | $154 |
| Polynovo North America LLC | 1 | $132 |
| Access Pro Medical, LLC | 1 | $29 |
| Organogenesis Inc. | 1 | $22 |
| Treace Medical Concepts, Inc. | 1 | $20 |
| Innovation Technologies Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,618 in reported general payments places this provider in the 95th percentile of 588 podiatrist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CiclopiroxCiclopirox Olamine | 266 | $5,210 |
| Ammonium Lactate | 162 | $2,048 |
| Doxycycline Hyclate | 16 | $1,630 |
| Clotrimazole | 41 | $1,378 |
| Ketoconazole | 56 | $612 |
| Mupirocin | 37 | $528 |
| Gentamicin Sulfate | 13 | $503 |
| Ciclopirox | 28 | $457 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 12 | $216 |
| Gabapentin | 15 | $147 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Miami Lakes
- James CottomSarasota$1.8M
- Caroline KiserFleming Island$206K
- Adam PerlerLargo$160K
- Desmond BellJacksonville$125K
- Jeffrey KarrLakeland$101K
- Marie WilliamsAventura$96K
- Todd BrennanTampa$88K
- Robert HooverLake Mary$71K
- Daniel BrandweinPompano Beach$70K
- John TorregrosaMiami$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.